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Abstract 009 – Table 1. Associations assessed at the medial tibiofemoral compartment
Incident BMLs (30-month) in subregions Crude OR (95% CI) Adjusted OR* (95% CI)
Absence (score = 0) Presence (score ≥ 1)
Normal cartilage morphology at baseline (grades 0 & 1) 3920 (68.2%) 111 (1.9%) 1.0 (reference) 1.0 (reference)
Cartilage damage at baseline (grade ≥ 2) 1526 (26.5%) 196 (3.4%) 4.2 (3.2, 5.4)** 3.5 (2.6, 4.6)**
No cartilage loss between BL and 30-month FU 5128 (89.1%) 197 (3.4%) 1.0 (reference) 1.0 (reference)
Incident (grade 0 at BL and grade ≥ 2 at FU) cartilage loss between BL and 30-month FU 170 (3%) 52 (0.9%) 7.1 (4.9, 10.3)** 7.1 (4.8, 10.5)**
Any cartilage loss between BL and 30-month FU 148 (2.6%) 58 (1%) 8.6 (5.9, 12.4)** 7.0 (4.7, 10.4)**
CI: conﬁdence intervals. * Adjusted for age, gender, BMI, knee alignment, meniscal damage, and meniscal extrusion. **Statistically signiﬁcant deﬁned as p<0.05.
Abstract 009 – Table 2. Associations assessed at the lateral tibiofemoral compartment
Incident BMLs (30-month) in subregions Crude OR (95% CI) Adjusted OR* (95% CI)
Absence (score = 0) Presence (score ≥ 1)
Normal cartilage morphology at baseline (grades 0 & 1) 4916 (80.3%) 60 (1%) 1.0 (reference) 1.0 (reference)
Cartilage damage at baseline (grade ≥ 2) 1080 (17.6%) 67 (1.1%) 4.6 (3.1, 7.0)** 3.4 (2.2, 5.2)**
No cartilage loss between BL and 30-month FU 5759 (94.1%) 88 (1.4%) 1.0 (reference) 1.0 (reference)
Incident (grade 0 at BL and grade ≥ 2 at FU) cartilage loss between BL and 30-month FU 138 (2.3%) 15 (0.3%) 5.7 (3.0, 10.9)** 4.3 (2.3, 8.3)**
Any cartilage loss between BL and 30-month FU 99 (1.6%) 24 (0.4%) 14.6 (8.4, 25.5)** 8.9 (4.8, 16.4)**
CI: conﬁdence intervals. *Adjusted for age, gender, BMI, knee alignment, meniscal damage, and meniscal extrusion. **Statistically signiﬁcant deﬁned as p<0.05.
All subjects with available baseline (BL) and 30-months follow-up (FU)
MRIs were included. MRI was performed on a 1.0T extremity system,
including sagittal and axial proton density fat-suppressed and coronal STIR
sequences. BL and FU MRIs were read using the semiquantitative WORMS
system by two musculoskeletal radiologists. Tibiofemoral compartments
were divided in 10 subregions. Cartilage morphology was scored from 0 to
6. BMLs were scored from 0 to 3. BL cartilage damage was deﬁned as grade
≥2. Subregions of knees showing cartilage loss overtime were divided into
two groups: incident (grades 0 at BL and ≥2 at FU) and progression (BL
cartilage damage with an increased grade at FU by at least 0.5). Incident
BMLs were deﬁned as grades 0 at BL and ≥1 at FU. Subregions with BL
BMLs were excluded. BL cartilage damage and cartilage loss over time
were considered predictors of incident BMLs (outcome), and the absence
of both BL cartilage damage and cartilage loss over time were considered
the reference group. We assessed the association of BL cartilage damage
and cartilage loss over time with incident BMLs in the same subregion
using logistic regression with generalized estimated equations to account
for correlations among the subregions within a knee (using one knee per
person). Adjustments for potential confounders were performed.
Results: 642 knees (1 knee per person, 5753 medial and 6123 lateral
subregions, respectively) were included (women 60.4%, mean age 61.9±7.6,
mean BMI 30.3±4.8). Medially, BL cartilage damage, incident cartilage loss
and progression of cartilage loss were signiﬁcantly associated with incident
BMLs, with adjusted odds ratios (ORs) of 3.5 [95% CI 2.6, 4.6], 7.1 [95%
CI 4.8, 10.5], and 7.0 [95% CI 4.7, 10.4] respectively (Table 1). Laterally,
the same predictors were signiﬁcantly associated with incident BMLs, with
adjusted ORs of 3.4 [95% CI 2.2, 5.3], 4.3 [95% CI 2.3, 8.3], and 8.9 [95% CI
4.8, 16.4] respectively (Table 2).
Conclusions: Prevalent cartilage damage and cartilage loss strongly predict
incident BMLs in the same subregion, supporting the close interrelation of
the osteochondral unit in progression of knee OA. If cartilage damage were
targeted in management of knee OA, it might prevent the development of
BMLs and the associated knee pain.
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Purpose: Osteoarthritis (OA) is a debilitating disease in which loss of
joint integrity is manifest as degradation of articular cartilage (AC) and
commonly osteophyte formation, synovial changes, and meniscus and liga-
ment pathologies. Despite this, the cellular and molecular processes of OA
remain elusive. Therefore, identiﬁcation of novel factors that precipitate
or confer protection against OA is very valuable. TGF-b and TGF-b related
proteins are already identiﬁed as key players, yet the role of follistatin-like
3 (FSTL-3), a natural inhibitor of TGF-b family members has not, however,
been explored. Our aim was to examine whether mice deﬁcient in FSTL-3
showed modiﬁcation in joint integrity resembling OA.
Methods: Knee joints from male FSTL-3 deﬁcient mice (FSTL3-KO and
heterogygotes, Hets) and litter-mate WT mice at 18-months (aged), and
younger, were examined. Multiple sections from regular intervals across
entire joints were stained with Toluidine blue and scored for AC lesions
(grade 0-6, normal - exposed bone), osteophyte maturity (0, none to 3,
fully mature) and any abnormal pathological features within the knee joint
noted.
Results: Expectedly, only very mild AC lesions were observed in aged
WT joints (maximum grade=1.75; mean grade=0.81). In contrast, aged
FSTL3 KO mice showed extremely severe AC lesions (maximum=5.33;
mean=4.2) with many joints exhibiting subchondral bone exposure. FSTL3
Hets showed intermediate levels of AC lesion severity (maximum=3;
mean=1.88). Partial growth plate closure was observed in both FSTL3 KO
and Hets. As expected, aged WT mice never showed premature growth
plate closure, osteophyte formation or changes in synovial, meniscus or
ligament integrity. Aged FSTL3 KO mice also showed synovial activation
and ﬁbrosis, and fully mature osteophytes (to grade 3) across all joint
compartments. Hets showed less marked synovial inﬁltration and ﬁbrosis,
and osteophytes were less pronounced and restricted in distribution. FSTL3
KO mice also showed disturbed meniscal structure by local osteophytes
and chondrogenesis/ossiﬁcation of ligaments. Examination of joints from a
few younger, 8-week old FSTL3 KO or Het mice showed no obvious changes
in joint structure.
Conclusions: Our data suggest that FSTL3 is required to maintain AC
integrity and joint health, and that overt OA-like changes emerge with age
in its absence. Our studies also reveal FSTL3 gene dose-dependency in OA
development. Such sensitivity to FSTL3 has not previously been observed
for other characteristic phenotypes in these mice, indicating a heightened
dependence on FSTL3 in protecting against OA. We are currently inves-
tigating the molecular mechanisms of FSTL3-mediated protection against
spontaneous OA and also conﬁrming its reliance upon ageing and the role
of gender and mechanical loading. Our ﬁndings, for the ﬁrst time, identify a
role for follistatin-like 3 in protecting against OA and pinpoint its regulation
as a new target for therapeutic intervention.
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Purpose: Leptin is an apidokine recently linked to inﬂammation and
arthritis and leptin has been proposed to be a metabolic factor connecting
obesity and osteoarthritis (OA). In the present study, the association of
leptin to proinﬂammatory cytokine interleukin-6 (IL-6) and matrix metal-
loproteinases (MMPs) in synovial ﬂuid from OA patients was assessed, and
further, the effects of leptin on the production of IL-6, MMPs and other
inﬂammatory factors in human OA cartilage were investigated.
